Holen Sie sich die Stockscreener-App
31.49
0.25%
0.09
Handel nachbörslich:
31.49
Schlusskurs vom Vortag:
$31.40
Offen:
$31.4
24-Stunden-Volumen:
639.55K
Relative Volume:
0.89
Marktkapitalisierung:
$1.39B
Einnahmen:
$78.02M
Nettoeinkommen (Verlust:
$-73.37M
KGV:
-23.86
EPS:
-1.32
Netto-Cashflow:
$-62.06M
1W Leistung:
+3.31%
1M Leistung:
+7.15%
6M Leistung:
+134.93%
1J Leistung:
+0.00%
1-Tages-Spanne:
$31.20
$32.53
1-Wochen-Bereich:
$28.36
$32.53
52-Wochen-Spanne:
$8.89
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Vergleichen Sie BBNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
31.49 | 1.38B | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
127.04 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.67 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.75 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.76 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.85 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Insider Sell: Mike Mensinger Sells 7,800 Shares of Beta Bionics Inc (BBNX) - GuruFocus
Mike Mensinger Sells 7,800 Shares of Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
Insider Selling: Beta Bionics (NASDAQ:BBNX) CFO Sells 20,000 Shares of Stock - MarketBeat
Beta Bionics CFO Sells 20,000 Shares - TradingView — Track All Markets
Bank of America Forecasts Strong Price Appreciation for Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
FOMO Trade: How Beta Bionics Inc stock reacts to inflationary pressuresWeekly Market Outlook & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Beta Bionics Reports Strong Q3 Growth Amid Challenges - MSN
Fourteen new option listings on November 12th - MSN
Artificial Pancreas System Market is set for steady growth to US$ - openPR.com
Beta Bionics (NASDAQ:BBNX) Trading Up 8.7%Should You Buy? - MarketBeat
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Market Review: How Beta Bionics Inc. stock performs during Fed tightening cyclesJuly 2025 Opening Moves & Verified Momentum Stock Ideas - Улправда
Why Beta Bionics Inc. stock is a must watch in 20252025 Price Action Summary & Low Risk High Win Rate Picks - Улправда
Why Beta Bionics Inc. stock is a value investor pickDollar Strength & Advanced Technical Analysis Signals - ulpravda.ru
Why Beta Bionics Inc. stock is rated strong buyMarket Growth Summary & Intraday High Probability Setup Alerts - DonanımHaber
Will Beta Bionics Inc. stock attract more institutional investorsTrade Entry Report & Weekly High Conviction Trade Ideas - DonanımHaber
How Beta Bionics Inc. stock performs during Fed tightening cyclesJuly 2025 Volume & Safe Capital Growth Stock Tips - Улправда
Truist Securities Maintains Beta Bionics (BBNX) Buy Recommendation - Nasdaq
Is Beta Bionics (BBNX) Overvalued After Its Recent Share Price Momentum? - Yahoo Finance
Beta Bionics (NASDAQ:BBNX) Sees Strong Trading Volume Following Analyst Upgrade - MarketBeat
Truist Securities Adjusts Price Target on Beta Bionics to $37 From $32, Maintains Buy Rating - marketscreener.com
Beta Bionics (NASDAQ:BBNX) Given New $37.00 Price Target at Truist Financial - MarketBeat
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas - MSN
Beta Bionics Earnings Notes - Trefis
Beta Bionics stock rating reiterated at Buy by Stifel - Investing.com Australia
Beta Bionics: It Has Been An Interesting Year (NASDAQ:BBNX) - Seeking Alpha
Beta Bionics, Inc. $BBNX Shares Purchased by Walleye Capital LLC - MarketBeat
BBNX FinancialsIncome Statement - Quiver Quantitative
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - The Manila Times
Divisadero Street Capital Management LP Purchases New Shares in Beta Bionics, Inc. $BBNX - MarketBeat
This Beta Bionics Insider Increased Their Holding By 130% Last Year - simplywall.st
Insider Selling: Beta Bionics (NASDAQ:BBNX) CFO Sells 1,427 Shares of Stock - MarketBeat
Feider Stephen (Beta Bionics) sells $41,862 in shares By Investing.com - Investing.com Canada
Top Executives at Beta Bionics, Inc. Cash Out on Stock Sales - TipRanks
Mensinger, Beta Bionics CPO, sells $31k in BBNX stock By Investing.com - Investing.com Nigeria
Feider Stephen (Beta Bionics) sells $41,862 in shares - Investing.com
Beta Bionics Executives Sell Shares for Tax Obligations - TradingView — Track All Markets
Officer Mensinger Files To Sell 1,063 Of Beta Bionics Inc [BBNX] - TradingView — Track All Markets
Mensinger, Beta Bionics CPO, sells $31k in BBNX stock - Investing.com
With Beta Bionics Stock Sliding, Have You Assessed The Risk? - Trefis
Insider Sell Alert: Adam Lezack Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus
Beta Bionics Executives Sell Shares - TradingView — Track All Markets
Midday Stock Roundup: Ingram Micro Falls - Orange County Business Journal
Beta Bionics (BBNX) Stock Analysis Report | Financials & Insights - Benzinga
Tech Watch: The Latest in Diabetes Tech News - Making Sense of Diabetes
BBNX Crosses Above Average Analyst Target - Nasdaq
Corporate – Shares – Settlement - Massachusetts Lawyers Weekly
Beta Bionics (NASDAQ:BBNX) Hits New 1-Year HighHere's Why - MarketBeat
Beta Bionics, Inc. (NASDAQ:BBNX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Technical Analysis of Beta Bionics, Inc. (NASDAQ:BBNX) - TradingView
What analysts say about Beta Bionics Inc stockMid Cap Growth Trends & Compound Your Gains With Quality Stocks - earlytimes.in
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):